Human IMP dehydrogenase. Kinetics and regulatory properties.
D000225:Adenine / Q000494:pharmacology; D000241:Adenosine / Q000494:pharmacology; D002250:Carbon Radioisotopes; D002458:Cell Fractionation; D002848:Chromatography, DEAE-Cellulose; D002854:Chromatography, Paper; D003600:Cytosol / Q000201:enzymology; D005260:Female; D006147:Guanine / Q000494:pharmacology; D006151:Guanosine / Q000494:pharmacology; D006801:Humans; D007292:Inosine Nucleotides; D007658:Ketone Oxidoreductases / Q000037:antagonists & inhibitors / Q000302:isolation & purification / Q000378:metabolism*; D007700:Kinetics; D015122:Mercaptopurine / Q000494:pharmacology; D008928:Mitochondria / Q000201:enzymology; D009243:NAD; D010920:Placenta / Q000201:enzymology*; D011247:Pregnancy; D011685:Purine Nucleotides / Q000494:pharmacology; D011742:Pyrimidine Nucleotides / Q000494:pharmacology; D013329:Structure-Activity Relationship; D014461:Ultracentrifugation
D002250:Carbon Radioisotopes; D007292:Inosine Nucleotides; D011685:Purine Nucleotides; D011742:Pyrimidine Nucleotides; D009243:NAD; D006151:Guanosine; D006147:Guanine; D015122:Mercaptopurine; D007658:Ketone Oxidoreductases; D000225:Adenine; D000241:Adenosine